Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain

Neurochemistry International

Volumn 55, Issue 5, 2009, Pages 275-281

  Beauchesne, Élizabeth ^a   Desjardins, Paul ^a   Hazell, Alan S ^a   Butterworth, Roger F ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood brain barrier; Matrix metalloproteinase 9; Thiamine deficiency; Tight junction proteins; Wernicke's encephalopathy

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN G; OCCLUDIN; PROTEIN ZO1; PROTEIN ZO2; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FRONTAL CORTEX; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THALAMUS; THIAMINE DEFICIENCY; TIGHT JUNCTION; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; BASE SEQUENCE; BLOOD-BRAIN BARRIER; BRAIN; DISEASE MODELS, ANIMAL; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAMINE DEFICIENCY; TIGHT JUNCTIONS; UP-REGULATION;

ANIMALIA; MUS;

EID: 67649344296     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.03.014     Document Type: Article

References (31)

1. Ando-Akatsuka Y., Saitou M., Hirase T., Kishi M., Sakakibara A., Itoh M., Yonemura S., Furuse M., and Tsukita S. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J. Cell Biol. 133 (1996) 43-47
2. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21 (2001) 7724-7732
3. Balda M.S., Whitney J.A., Flores C., Gonzalez S., Cereijido M., and Matter K. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J. Cell Biol. 134 (1996) 1031-1049
4. Bamforth S.D., Kniesel U., Wolburg H., Engelhardt B., and Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J. Cell. Sci. 112 (1999) 1879-1888
5. Calingasan N.Y., and Gibson G.E. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann. N.Y. Acad. Sci. 903 (2000) 353-356
6. Calingasan N.Y., Huang P.L., Chun H.S., Fabian A., and Gibson G.E. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism. J. Neuropathol. Exp. Neurol. 59 (2000) 207-217
7. Calingasan N.Y., Baker H., Sheu K.R., and Gibson G.E. Blood-brain barrier abnormalities in vulnerable brain regions during thiamine deficiency. Exp. Neurol. 134 (1995) 64-72
8. Fanning A.S., Jameson B.J., Jesaitis L.A., and Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273 (1998) 29745-29753
9. Harata N., and Iwasaki Y. Evidence for early blood-brain barrier breakdown in experimental thiamine deficiency in the mouse. Metab. Brain Dis. 10 (1995) 159-174
10. Hawkins B.T., Lundeen T.F., Norwood K.M., Brooks H.L., and Egleton R.D. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 50 (2007) 202-211
11. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005) 173-185
12. Heo J.H., Han S.W., and Lee S.K. Free radicals as triggers of brain edema formation after stroke. Free Radic. Biol. Med. 39 (2005) 51-70
13. Heroux M., and Butterworth R.F. In: Boulton A., Baker G.B., and Butterworth R.F. (Eds). Animal Models of Neurological Disease (1992), Humana Press, Totowa, NJ 95-131
14. Itoh M., Morita K., and Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J. Biol. Chem. 274 (1999) 5981-5986
15. Itoh M., Nagafuchi A., Yonemura S., Kitani-Yasuda T., Tsukita S., and Tsukita S. The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J. Cell Biol. 121 (1993) 491-502
16. Ke Z.J., and Gibson G.E. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem. Int. 45 (2004) 361-369
17. Kieseier B.C., Seifert T., Giovannoni G., and Hartung H.P. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology 53 (1999) 20-25
18. Kirk J., Plumb J., Mirakhur M., and McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 201 (2003) 319-327
19. Kruse M., Navarro D., Desjardins P., and Butterworth R.F. Increased brain endothelial nitric oxide synthase expression in thiamine deficiency: relationship to selective vulnerability. Neurochem. Int. 45 (2004) 49-56
20. McColl B.W., Rothwell N.J., and Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28 (2008) 9451-9462
21. Morgan L., Shah B., Rivers L.E., Barden L., Groom A.J., Chung R., Higazi D., Desmond H., Smith T., and Staddon J.M. Inflammation and dephosphorylation of the tight junction protein occludin in an experimental model of multiple sclerosis. Neuroscience 147 (2007) 664-673
22. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. second edition (2003), Academic Press, San Diego
23. Raynal F., Michot B., and Bachellerie J.P. Complete nucleotide sequence of mouse 18S rRNA gene: comparison with other available homologs. FEBS Lett. 167 (1984) 263-268
24. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
25. Rozen S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132 (2000) 365-386
26. Todd K.G., and Butterworth R.F. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia 25 (1999) 190-198
27. Todd K.G., and Butterworth R.F. Increased neuronal cell survival after L-deprenyl treatment in experimental thiamine deficiency. J. Neurosci. Res. 52 (1998) 240-246
28. Troncoso J.C., Johnston M.V., Hess K.M., Griffin J.W., and Price D.L. Model of Wernicke's encephalopathy. Arch. Neurol. 38 (1981) 350-354
29. Watanabe I., Tomita T., Hung K.S., and Iwasaki Y. Edematous necrosis in thiamine-deficient encephalopathy of the mouse. J. Neuropathol. Exp. Neurol. 40 (1981) 454-471
30. Yang Y., Estrada E.Y., Thompson J.F., Liu W., and Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27 (2007) 697-709
31. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008) 178-200